These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10832149)

  • 1. [The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E
    Ital Heart J Suppl; 2000 Apr; 1(4):577-8. PubMed ID: 10832149
    [No Abstract]   [Full Text] [Related]  

  • 2. [Out-of- or in-hospital occurrences of malignant ventricular tachyarrhythmias: the prognostic significance in the population enrolled in the AVID study. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E
    Ital Heart J Suppl; 2000 Apr; 1(4):579-80. PubMed ID: 10832150
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary prophylactic treatment with implantable defibrillator in high risk patients].
    Møller M; Haghfelt T
    Ugeskr Laeger; 2000 Jul; 162(31):4160-1. PubMed ID: 10962922
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implantable defibrillator--with focus on primary prevention. Detailed patient information about risks and benefits is required].
    Jensen SM; Kesek M
    Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3236, 3238-41. PubMed ID: 20101834
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
    Domanski MJ; Sakseena S; Epstein AE; Hallstrom AP; Brodsky MA; Kim S; Lancaster S; Schron E
    J Am Coll Cardiol; 1999 Oct; 34(4):1090-5. PubMed ID: 10520795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Automatic defibrillator or anti-arrhythmia drugs for the therapy of patients who survived heart arrest or with syncopal ventricular arrhythmias? A critical analysis of the models relative to the studies in progress].
    Cappato R; Kuck KH
    G Ital Cardiol; 1994 Dec; 24(12):1613-21. PubMed ID: 7883135
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP;
    Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of ventricular tachycardia].
    Hermida JS; Jarry G; Rey JL; Quiret JC
    Arch Mal Coeur Vaiss; 1998 Mar; 91 Spec No 1():15-20. PubMed ID: 9749280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
    Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
    Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 14. Circadian pattern of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Wood MA; Simpson PM; London WB; Stambler BS; Herre JM; Bernstein RC; Ellenbogen KA
    J Am Coll Cardiol; 1995 Mar; 25(4):901-7. PubMed ID: 7884095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable ventricular tachycardia is not a benign rhythm: insights from the AVID registry. Antiarrhythmics versus Implantable Defibrillators.
    Indian Heart J; 2001; 53(3):377. PubMed ID: 11547738
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.
    Schukro C; Leitner L; Siebermair J; Pezawas T; Stix G; Kastner J; Schmidinger H
    Int J Cardiol; 2013 Sep; 167(6):3006-10. PubMed ID: 23017814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 19. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Hickey K; Curtis AB; Lancaster S; Larsen G; Warwick D; McAnulty J; Mitchell LB
    Am Heart J; 2001 Jul; 142(1):99-104. PubMed ID: 11431664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.